Cargando…
Mucosal-Associated Invariant T Cells Display Diminished Effector Capacity in Oesophageal Adenocarcinoma
Oesophageal adenocarcinoma (OAC) is an aggressive malignancy with poor prognosis, and incidence is increasing rapidly in the Western world. Mucosal-associated invariant T (MAIT) cells recognize bacterial metabolites and kill infected cells, yet their role in OAC is unknown. We aimed to elucidate the...
Autores principales: | , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6635552/ https://www.ncbi.nlm.nih.gov/pubmed/31354725 http://dx.doi.org/10.3389/fimmu.2019.01580 |
_version_ | 1783435904849805312 |
---|---|
author | Melo, Ashanty M. O'Brien, Aisling M. Phelan, James J. Kennedy, Susan A. Wood, Nicole A. W. Veerapen, Natacha Besra, Gurdyal S. Clarke, Niamh E. Foley, Emma K. Ravi, Akshaya MacCarthy, Finbar O'Toole, Dermot Ravi, Narayamasami Reynolds, John V. Conroy, Melissa J. Hogan, Andrew E. O'Sullivan, Jacintha Dunne, Margaret R. |
author_facet | Melo, Ashanty M. O'Brien, Aisling M. Phelan, James J. Kennedy, Susan A. Wood, Nicole A. W. Veerapen, Natacha Besra, Gurdyal S. Clarke, Niamh E. Foley, Emma K. Ravi, Akshaya MacCarthy, Finbar O'Toole, Dermot Ravi, Narayamasami Reynolds, John V. Conroy, Melissa J. Hogan, Andrew E. O'Sullivan, Jacintha Dunne, Margaret R. |
author_sort | Melo, Ashanty M. |
collection | PubMed |
description | Oesophageal adenocarcinoma (OAC) is an aggressive malignancy with poor prognosis, and incidence is increasing rapidly in the Western world. Mucosal-associated invariant T (MAIT) cells recognize bacterial metabolites and kill infected cells, yet their role in OAC is unknown. We aimed to elucidate the role of MAIT cells during cancer development by characterizing the frequency, phenotype, and function of MAIT cells in human blood and tissues, from OAC and its pre-malignant inflammatory condition Barrett's oesophagus (BO). Blood and tissues were phenotyped by flow cytometry and conditioned media from explanted tissue was used to model the effects of the tumor microenvironment on MAIT cell function. Associations were assessed between MAIT cell frequency, circulating inflammatory markers, and clinical parameters to elucidate the role of MAIT cells in inflammation driven cancer. MAIT cells were decreased in BO and OAC blood compared to healthy controls, but were increased in oesophageal tissues, compared to BO-adjacent tissue, and remained detectable after neo-adjuvant treatment. MAIT cells in tumors expressed CD8, PD-1, and NKG2A but lower NKG2D than BO cohorts. MAIT cells produced less IFN-γ and TNF-α in the presence of tumor-conditioned media. OAC cell line viability was reduced upon exposure to expanded MAIT cells. Serum levels of chemokine IP-10 were inversely correlated with MAIT cell frequency in both tumors and blood. MAIT cells were higher in the tumors of node-negative patients, but were not significantly associated with other clinical parameters. This study demonstrates that OAC tumors are infiltrated by MAIT cells, a type of CD8 T cell featuring immune checkpoint expression and cytotoxic potential. These findings may have implications for immunotherapy and immune scoring approaches. |
format | Online Article Text |
id | pubmed-6635552 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-66355522019-07-26 Mucosal-Associated Invariant T Cells Display Diminished Effector Capacity in Oesophageal Adenocarcinoma Melo, Ashanty M. O'Brien, Aisling M. Phelan, James J. Kennedy, Susan A. Wood, Nicole A. W. Veerapen, Natacha Besra, Gurdyal S. Clarke, Niamh E. Foley, Emma K. Ravi, Akshaya MacCarthy, Finbar O'Toole, Dermot Ravi, Narayamasami Reynolds, John V. Conroy, Melissa J. Hogan, Andrew E. O'Sullivan, Jacintha Dunne, Margaret R. Front Immunol Immunology Oesophageal adenocarcinoma (OAC) is an aggressive malignancy with poor prognosis, and incidence is increasing rapidly in the Western world. Mucosal-associated invariant T (MAIT) cells recognize bacterial metabolites and kill infected cells, yet their role in OAC is unknown. We aimed to elucidate the role of MAIT cells during cancer development by characterizing the frequency, phenotype, and function of MAIT cells in human blood and tissues, from OAC and its pre-malignant inflammatory condition Barrett's oesophagus (BO). Blood and tissues were phenotyped by flow cytometry and conditioned media from explanted tissue was used to model the effects of the tumor microenvironment on MAIT cell function. Associations were assessed between MAIT cell frequency, circulating inflammatory markers, and clinical parameters to elucidate the role of MAIT cells in inflammation driven cancer. MAIT cells were decreased in BO and OAC blood compared to healthy controls, but were increased in oesophageal tissues, compared to BO-adjacent tissue, and remained detectable after neo-adjuvant treatment. MAIT cells in tumors expressed CD8, PD-1, and NKG2A but lower NKG2D than BO cohorts. MAIT cells produced less IFN-γ and TNF-α in the presence of tumor-conditioned media. OAC cell line viability was reduced upon exposure to expanded MAIT cells. Serum levels of chemokine IP-10 were inversely correlated with MAIT cell frequency in both tumors and blood. MAIT cells were higher in the tumors of node-negative patients, but were not significantly associated with other clinical parameters. This study demonstrates that OAC tumors are infiltrated by MAIT cells, a type of CD8 T cell featuring immune checkpoint expression and cytotoxic potential. These findings may have implications for immunotherapy and immune scoring approaches. Frontiers Media S.A. 2019-07-10 /pmc/articles/PMC6635552/ /pubmed/31354725 http://dx.doi.org/10.3389/fimmu.2019.01580 Text en Copyright © 2019 Melo, O'Brien, Phelan, Kennedy, Wood, Veerapen, Besra, Clarke, Foley, Ravi, MacCarthy, O'Toole, Ravi, Reynolds, Conroy, Hogan, O'Sullivan and Dunne. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Immunology Melo, Ashanty M. O'Brien, Aisling M. Phelan, James J. Kennedy, Susan A. Wood, Nicole A. W. Veerapen, Natacha Besra, Gurdyal S. Clarke, Niamh E. Foley, Emma K. Ravi, Akshaya MacCarthy, Finbar O'Toole, Dermot Ravi, Narayamasami Reynolds, John V. Conroy, Melissa J. Hogan, Andrew E. O'Sullivan, Jacintha Dunne, Margaret R. Mucosal-Associated Invariant T Cells Display Diminished Effector Capacity in Oesophageal Adenocarcinoma |
title | Mucosal-Associated Invariant T Cells Display Diminished Effector Capacity in Oesophageal Adenocarcinoma |
title_full | Mucosal-Associated Invariant T Cells Display Diminished Effector Capacity in Oesophageal Adenocarcinoma |
title_fullStr | Mucosal-Associated Invariant T Cells Display Diminished Effector Capacity in Oesophageal Adenocarcinoma |
title_full_unstemmed | Mucosal-Associated Invariant T Cells Display Diminished Effector Capacity in Oesophageal Adenocarcinoma |
title_short | Mucosal-Associated Invariant T Cells Display Diminished Effector Capacity in Oesophageal Adenocarcinoma |
title_sort | mucosal-associated invariant t cells display diminished effector capacity in oesophageal adenocarcinoma |
topic | Immunology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6635552/ https://www.ncbi.nlm.nih.gov/pubmed/31354725 http://dx.doi.org/10.3389/fimmu.2019.01580 |
work_keys_str_mv | AT meloashantym mucosalassociatedinvarianttcellsdisplaydiminishedeffectorcapacityinoesophagealadenocarcinoma AT obrienaislingm mucosalassociatedinvarianttcellsdisplaydiminishedeffectorcapacityinoesophagealadenocarcinoma AT phelanjamesj mucosalassociatedinvarianttcellsdisplaydiminishedeffectorcapacityinoesophagealadenocarcinoma AT kennedysusana mucosalassociatedinvarianttcellsdisplaydiminishedeffectorcapacityinoesophagealadenocarcinoma AT woodnicoleaw mucosalassociatedinvarianttcellsdisplaydiminishedeffectorcapacityinoesophagealadenocarcinoma AT veerapennatacha mucosalassociatedinvarianttcellsdisplaydiminishedeffectorcapacityinoesophagealadenocarcinoma AT besragurdyals mucosalassociatedinvarianttcellsdisplaydiminishedeffectorcapacityinoesophagealadenocarcinoma AT clarkeniamhe mucosalassociatedinvarianttcellsdisplaydiminishedeffectorcapacityinoesophagealadenocarcinoma AT foleyemmak mucosalassociatedinvarianttcellsdisplaydiminishedeffectorcapacityinoesophagealadenocarcinoma AT raviakshaya mucosalassociatedinvarianttcellsdisplaydiminishedeffectorcapacityinoesophagealadenocarcinoma AT maccarthyfinbar mucosalassociatedinvarianttcellsdisplaydiminishedeffectorcapacityinoesophagealadenocarcinoma AT otooledermot mucosalassociatedinvarianttcellsdisplaydiminishedeffectorcapacityinoesophagealadenocarcinoma AT ravinarayamasami mucosalassociatedinvarianttcellsdisplaydiminishedeffectorcapacityinoesophagealadenocarcinoma AT reynoldsjohnv mucosalassociatedinvarianttcellsdisplaydiminishedeffectorcapacityinoesophagealadenocarcinoma AT conroymelissaj mucosalassociatedinvarianttcellsdisplaydiminishedeffectorcapacityinoesophagealadenocarcinoma AT hoganandrewe mucosalassociatedinvarianttcellsdisplaydiminishedeffectorcapacityinoesophagealadenocarcinoma AT osullivanjacintha mucosalassociatedinvarianttcellsdisplaydiminishedeffectorcapacityinoesophagealadenocarcinoma AT dunnemargaretr mucosalassociatedinvarianttcellsdisplaydiminishedeffectorcapacityinoesophagealadenocarcinoma |